litlas
Log inCreate account

Jayesh Desai

Active 1989–2025

130
Papers
26,611
Citations
65
h-index
121
i10-index

Citations

Citations per year for Jayesh Desai1990: 1 citations1991: 1 citations1992: 1 citations1995: 1 citations2000: 1 citations2004: 1 citations2005: 16 citations2006: 21 citations2007: 83 citations2008: 83 citations2009: 147 citations2010: 107 citations2011: 100 citations2012: 104 citations2013: 104 citations2014: 132 citations2015: 109 citations2016: 153 citations2017: 222 citations2018: 265 citations2019: 820 citations2020: 1,327 citations2021: 1,602 citations2022: 1,309 citations2023: 1,017 citations2024: 1,589 citations2025: 946 citations2026: 22 citations1993–1994: no citations, so these years are not shown1996–1999: no citations, so these years are not shown2001–2003: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,364 citing papers, 25.2% of this breakdownChina: 1,731 citing papers, 12.9% of this breakdownItaly: 853 citing papers, 6.4% of this breakdownUnited Kingdom: 720 citing papers, 5.4% of this breakdownGermany: 631 citing papers, 4.7% of this breakdownFrance: 630 citing papers, 4.7% of this breakdownSpain: 533 citing papers, 4% of this breakdownJapan: 482 citing papers, 3.6% of this breakdownNetherlands: 413 citing papers, 3.1% of this breakdownAustralia: 376 citing papers, 2.8% of this breakdownCanada: 342 citing papers, 2.6% of this breakdownSwitzerland: 277 citing papers, 2.1% of this breakdown
0%25.2%Other 22.5%

Institutions

Fields

  • Medicine60.4%
  • Biochemistry, Genetics and Molecular Biology31%
  • Immunology and Microbiology3.6%
  • Neuroscience1%
  • Chemistry1%
  • Engineering0.9%
  • Other2.1%

Topics

  • Cancer Immunotherapy and Biomarkers6.8%
  • Cancer Genomics and Diagnostics6.5%
  • Colorectal Cancer Treatments and Studies6.2%
  • Genetic factors in colorectal cancer5%
  • Lung Cancer Treatments and Mutations3.7%
  • Cancer Cells and Metastasis2.1%
  • Other69.7%

Coauthors

All papers

Open in search
  1. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity

    Authors: Jude Canon, Karen Rex, Anne Y. Saiki, Christopher Mohr, Keegan S. Cooke, Dhanashri Bagal, Kevin Gaida, Tyler Holt, Charles G. Knutson, Neelima Koppada, Brian A. Lanman, Jonathan Werner, Aaron S. Rapaport, Tisha San Miguel, Roberto Ortiz, Tao Osgood, Ji-Rong Sun, Xiaochun Zhu, John D. McCarter, Laurie P. Volak, Brett E. Houk, Marwan Fakih, Bert H. O’Neil, Timothy Price, Gerald S. Falchook, Jayesh Desai, James Kuo, Ramaswamy Govindan, David S. Hong, Wenjun Ouyang, Haby Henary, Tara Arvedson, Victor J. Cee, J. Russell Lipford - Nature 2019 cited by 2,303

  2. KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors

    Authors: David S. Hong, Marwan Fakih, John H. Strickler, Jayesh Desai, Gregory A. Durm, Geoffrey I. Shapiro, Gerald S. Falchook, Timothy Price, Adrian G. Sacher, Crystal S. Denlinger, Yung‐Jue Bang, Grace K. Dy, John C. Krauss, Yasutoshi Kuboki, James Kuo, Andrew L. Coveler, Keunchil Park, Tae Won Kim, Fabrice Barlési, Pamela N. Münster, Suresh S. Ramalingam, Timothy F. Burns, Funda Meric‐Bernstam, Haby Henary, Jude Ngang, Gataree Ngarmchamnanrith, June Myung Kim, Brett E. Houk, Jude Canon, J. Russell Lipford, Gregory Friberg, Piro Lito, Ramaswamy Govindan, Bob T. Li - New England Journal of Medicine 2020 cited by 1,687

  3. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

    Authors: Michael J. Overman, Ray McDermott, Joseph L. Leach, Sara Lonardi, Heinz‐Josef Lenz, Michael A. Morse, Jayesh Desai, Andrew Hill, Michael D. Axelson, Rebecca A. Moss, Monica V. Goldberg, Z. Alexander Cao, Jean-Marie Ledeine, Gregory A. Maglinte, Scott Kopetz, Thierry André - The Lancet Oncology 2017 cited by 2,816

  4. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

    Authors: Scott Kopetz, Axel Grothey, Rona Yaeger, Eric Van Cutsem, Jayesh Desai, Takayuki Yoshino, Harpreet Wasan, Fortunato Ciardiello, Fotios Loupakis, Yong Sang Hong, Neeltje Steeghs, Tormod Kyrre Guren, Hendrik‐Tobias Arkenau, Pilar García‐Alfonso, Per Pfeiffer, Sergey Orlov, Sara Lonardi, Elena Élez, Tae-Won Kim, Jan H.M. Schellens, Christina Guo, Asha Krishnan, Jeroen Dekervel, Van K. Morris, Aitana Calvo Ferrandiz, Line Schmidt Tarpgaard, Michael Braun, Ashwin Gollerkeri, Christopher Hunt Keir, Kati Maharry, Michael D. Pickard, Janna Christy‐Bittel, Lisa Anderson, Victor Sandor, Josep Tabernero - New England Journal of Medicine 2019 cited by 1,465

  5. Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation

    Authors: Adrian G. Sacher, Patricia LoRusso, Manish R. Patel, Wilson H. Miller, Elena Garralda, Martin Förster, Armando Santoro, Alejandro Falcón, Tae Won Kim, Luis Paz‐Ares, Samantha Bowyer, Maria de Miguel, Sae‐Won Han, Matthew Krebs, Jong Seok Lee, Michael L. Cheng, Kathryn C. Arbour, Erminia Massarelli, Yoonha Choi, Zhen Shi, Sandhya Mandlekar, Mark T. Lin, Stephanie Royer‐Joo, Julie Chang, Neekesh V. Dharia, Jennifer L. Schutzman, Jayesh Desai - New England Journal of Medicine 2023 cited by 294

  6. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

    Authors: Jeanne Tie, Yuxuan Wang, Cristian Tomasetti, Lu Li, Simeon Springer, Isaac Kinde, Natalie Silliman, Mark Tacey, Hui‐Li Wong, Michael Christie, Suzanne Kosmider, Iain Skinner, Rachel Wong, Malcolm Steel, Ben Tran, Jayesh Desai, Ian T. Jones, Andrew Haydon, Theresa Hayes, Timothy Price, Robert L. Strausberg, Luis A. Díaz, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Peter Gibbs - Science Translational Medicine 2016 cited by 1,469

  7. Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

    Authors: Josep Tabernero, Axel Grothey, Eric Van Cutsem, Rona Yaeger, Harpreet Wasan, Takayuki Yoshino, Jayesh Desai, Fortunato Ciardiello, Fotios Loupakis, Yong Sang Hong, Neeltje Steeghs, Tormod Kyrre Guren, Hendrik-Tobias Arkenau, Pilar García‐Alfonso, Elena Élez, Ashwin Gollerkeri, Kati Maharry, Janna Christy‐Bittel, Scott Kopetz - Journal of Clinical Oncology 2021 cited by 544

  8. Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

    Authors: William D. Tap, Hans Gelderblom, Emanuela Palmerini, Jayesh Desai, Sebastian Bauer, Jean‐Yves Blay, Thierry Alcindor, Kristen N. Ganjoo, Javier Martín‐Broto, Christopher W. Ryan, David M. Thomas, Charles Peterfy, John H. Healey, Michiel A. J. van de Sande, Heather L. Gelhorn, Dale E. Shuster, Qiang Wang, Antoine Yver, Henry H. Hsu, Paul Lin, Sandra Tong-Starksen, Silvia Stacchiotti, Andrew J. Wagner - The Lancet 2019 cited by 474

  9. Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

    Authors: Grace K. Dy, Ramaswamy Govindan, Vamsidhar Velcheti, Gerald S. Falchook, Antoîne Italiano, Jürgen Wolf, Adrian G. Sacher, Toshiaki Takahashi, Suresh S. Ramalingam, Christophe Dooms, Dong‐Wan Kim, Alfredo Addeo, Jayesh Desai, Martin Schüler, Pascale Tomasini, David S. Hong, Piro Lito, Qui Tran, Simon Jones, Abraham Anderson, Antreas Hindoyan, Wendy Snyder, Ferdinandos Skoulidis, Bob T. Li - Journal of Clinical Oncology 2023 cited by 149

  10. Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

    Authors: Jayesh Desai, Guzmán Alonso, Se Hyun Kim, Andrés Cervantes, Thomas B. Karasic, Laura Medina, Einat Shacham‐Shmueli, Rasha Cosman, Alejandro Falcón, Eelke Gort, Tormod Kyrre Guren, Erminia Massarelli, Wilson H. Miller, Luis Paz‐Ares, Hans Prenen, Alessio Amatu, Chiara Cremolini, Tae Won Kim, Víctor Moreno, Sai‐Hong Ignatius Ou, Alessandro Passardi, Adrian G. Sacher, Armando Santoro, Rafał Stec, Susanna V. Ulahannan, Kathryn C. Arbour, Patricia LoRusso, Jia Luo, Manish R. Patel, Yoonha Choi, Zhen Shi, Sandhya Mandlekar, Mark T. Lin, Stephanie Royer‐Joo, Julie Chang, Tomi Jun, Neekesh V. Dharia, Jennifer L. Schutzman, GO42144 Investigator and Study Group, Sae-Won Han - Nature Medicine 2023 cited by 122

  11. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

    Authors: Jeanne Tie, Isaac Kinde, Y. Wang, Hui‐Li Wong, Justin Kelvin Roebert, Michael Christie, Mark Tacey, Rachel Wong, Madhu Singh, Christos S. Karapetis, Jayesh Desai, Ben Tran, R L Strausberg, Luis A. Díaz, Nikolaos G. Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Peter Gibbs - Annals of Oncology 2015 cited by 644

  12. Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer

    Authors: Scott Kopetz, Jayesh Desai, Emily Chan, J. Randolph Hecht, Peter J. O’Dwyer, Dipen M. Maru, Van K. Morris, Filip Jankú, Arvind Dasari, Woonbok Chung, Jean‐Pierre J. Issa, Peter Gibbs, Brian P. James, Garth Powis, K. B. Nolop, Suman Bhattacharya, Leonard B. Saltz - Journal of Clinical Oncology 2015 cited by 693

  13. First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors

    Authors: Johanna C. Bendell, Patricia LoRusso, Michael J. Overman, Anne M. Noonan, Dong‐Wan Kim, John H. Strickler, Sang‐We Kim, Stephen Clarke, Thomas J. George, Peter Grimison, Minal Barve, Manik Amin, Jayesh Desai, Trisha M. Wise‐Draper, Steven Eck, Yu Jiang, Anis A. Khan, Yuling Wu, Philip Martin, Zachary A. Cooper, Nairouz Elgeioushi, Nancy K. Mueller, Rakesh Kumar, Sandip Pravin Patel - Cancer Immunology Immunotherapy 2023 cited by 109

  14. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

    Authors: George D. Demetri, Allan T. van Oosterom, Christopher R. Garrett, Martin E. Blackstein, Manisha H. Shah, Jaap Verweij, Grant A. McArthur, Ian Judson, Michael C. Heinrich, Jeffrey A. Morgan, Jayesh Desai, Christopher D.�M. Fletcher, Suzanne George, Carlo L. Bello, Xin Huang, Charles M. Baum, Paolo G. Casali - The Lancet 2006 cited by 2,595

  15. Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

    Authors: Silvia Stacchiotti, Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée, Dario Callegaro, Paolo G. Casali, RuRu Chun-Ju Chiang, George D. Demetri, Elisabeth G. Demicco, Jayesh Desai, Mikael Eriksson, Hans Gelderblom, Suzanne George, Mrinal M. Gounder, Alessandro Gronchi, Abha A. Gupta, Rick L. Haas, Andrea Hayes‐Jardon, Peter Hohenberger, Kevin B. Jones, Robin L. Jones, Bernd Kasper, Akira Kawai, David G. Kirsch, Eugene S. Kleinerman, Axel Le Cesne, Jiwon Lim, María Dolores Chirlaque López, Roberta Maestro, Rafael Marcos‐Gragera, Javier Martín‐Broto, Tomohiro Matsuda, Olivier Mir, Shreyaskumar Patel, Chandrajit P. Raut, Albiruni R. Abdul Razak, Damon R. Reed, Piotr Rutkowski, Roberta Sanfilippo, Marta Sbaraglia, Inga‐Marie Schaefer, D. Strauß, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Winette T.A. van der Graaf, Winan J. van Houdt, Otto Visser, Margaret von Mehren, Andrew J. Wagner, Breelyn A. Wilky, Young‐Joo Won, Christopher D.�M. Fletcher, Angelo Paolo Dei Tos, Annalisa Trama - Cancer 2021 cited by 227

  16. T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models

    Authors: Déborah Meyran, Joe Jiang Zhu, Jeanne Butler, Daniela Tantalo, Sean Macdonald, Thu Ngoc Nguyen, Minyu Wang, Niko Thio, Criselle D’Souza, Vicky Mengfei Qin, Clare Y. Slaney, Aaron J Harrison, Kevin Sek, Pasquale Petrone, Kevin Thia, Lauren Giuffrida, Andrew M. Scott, Rachael Terry, Ben Tran, Jayesh Desai, H. Miles Prince, Simon J. Harrison, Paul A. Beavis, Michael H. Kershaw, Benjamin Solomon, Paul G. Ekert, Joseph A. Trapani, Phillip K. Darcy, Paul J. Neeson - Science Translational Medicine 2023 cited by 97

  17. Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors

    Authors: Tae Won Kim, Philippe L. Bédard, Patricia LoRusso, Michael S. Gordon, Johanna C. Bendell, Do‐Youn Oh, Myung‐Ju Ahn, Elena Garralda, Sandra P. D’Angelo, Jayesh Desai, F. Stephen Hodi, Zev A. Wainberg, Jean‐Pierre Delord, Phillippe A. Cassier, Andrés Cervantes, Marta Gil-Martín, Benjamin Wu, Namrata S. Patil, Yanling Jin, Tien Hoang, Diana Mendus, Xiaohui Wen, Raymond D. Meng, Byoung Chul Cho - JAMA Oncology 2023 cited by 63

  18. Bispecific antibodies: advancing precision oncology

    Authors: M. Zurita Herrera, G. Pretelli, Jayesh Desai, Elena Garralda, Lillian L. Siu, Thiago M. Steiner, Lewis Au - Trends in cancer 2024 cited by 137

  19. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

    Authors: Ben Tran, Scott Kopetz, Jeanne Tie, Peter Gibbs, Zhi‐Qin Jiang, Christopher H. Lieu, Atin Agarwal, Dipen M. Maru, Oliver M. Sieber, Jayesh Desai - Cancer 2011 cited by 801

  20. Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

    Authors: Matthew D. Hellmann, T. W. Kim, Chul‐min Lee, B-C. Goh, Wilson H. Miller, Do‐Youn Oh, R. Jamal, C.E. Chee, Laura Q.M. Chow, Justin F. Gainor, Jayesh Desai, Benjamin Solomon, Meghna Das Thakur, Bethany Pitcher, Paul Foster, Genevive Hernandez, Matthew Wongchenko, Edward Cha, Yu Jeong Bang, Lillian L. Siu, Johanna C. Bendell - Annals of Oncology 2019 cited by 190

  21. Abstract CT006: First-in-class, first-in-human phase 1 trial of VT3989, an inhibitor of yes-associated protein (YAP)/transcriptional enhancer activator domain (TEAD), in patients (pts) with advanced solid tumors enriched for malignant mesothelioma and other tumors with neurofibromatosis 2 (NF2) mutations

    Authors: Timothy A. Yap, David J. Kwiatkowski, Jayesh Desai, Ibiayi Dagogo‐Jack, Michael Millward, Hedy L. Kindler, Anthony W. Tolcher, Sophia Frentzas, Archie Thurston, Len Post, F Andrew Dorr - Cancer Research 2023 cited by 64

  22. Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors

    Authors: Jayesh Desai, Hui Gan, Catherine Barrow, Michael B. Jameson, Victoria Atkinson, Andrew Haydon, Michael Millward, Stephen Begbie, Michael P. Brown, Ben Markman, W. K. Patterson, Andrew Hill, Lisa G. Horvath, Adnan Nagrial, Gary Richardson, Christopher Jackson, Michael Friedländer, Phillip Parente, Ben Tran, Lai Wang, Yunxin Chen, Zhiyu Tang, Wendy Huang, John Wu, Dewan Zeng, Lusong Luo, Benjamin Solomon - Journal of Clinical Oncology 2020 cited by 109

  23. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

    Authors: Tammy F. Chu, Maria A. Rupnick, Risto Kerkelä, Susan M. Dallabrida, David Zurakowski, Lisa Nguyen, Kathleen C. Woulfe, Elke Pravda, Flávia Cassiola, Jayesh Desai, Suzanne George, David M. Harris, Nesreen S. Ismail, Jey-Hsin Chen, Frederick J. Schöen, Annick D. Van den Abbeele, George D. Demetri, Thomas Force, Ming Hui Chen, Jeffrey A. Morgan - The Lancet 2007 cited by 1,073

  24. SMAD2,SMAD3andSMAD4Mutations in Colorectal Cancer

    Authors: Nicholas I. Fleming, Robert N. Jorissen, Dmitri Mouradov, Michael Christie, Anuratha Sakthianandeswaren, Michelle Palmieri, Fiona Day, Shan Li, Cary Tsui, Lara Lipton, Jayesh Desai, Ian T. Jones, Stephen McLaughlin, Robyn L. Ward, Nicholas J. Hawkins, Andrew Ruszkiewicz, James W. Moore, Hong‐Jian Zhu, John M. Mariadason, Antony W. Burgess, Dana Busam, Qi Zhao, Robert L. Strausberg, Peter Gibbs, Oliver M. Sieber - Cancer Research 2012 cited by 328